GLP-1

Survival and recurrence with GLP-1 receptor agonists in breast cancer - EurekAlert!

Study shows for benefits on obesity-linked conditions of losing more weight with GLP-1 treatment - EurekAlert!

Bariatric surgery more effective than GLP-1 drugs at preventing heart attacks, stroke and death in older adults - EurekAlert!

Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings - EurekAlert!

Study finds bariatric surgery less costly than GLP-1 drugs over time - EurekAlert!

Do GLP-1 drugs like Ozempic prevent cancer?

The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma - EurekAlert!

The Lancet: GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial - EurekAlert!

GLP-1 drugs have long-term benefit for heart health - EurekAlert!

New study examines stigma toward women who lose weight using GLP-1 medications - EurekAlert!

Some GLP-1 drugs are more effective for those with specific gene variants

One in 10 people may have resistance to GLP-1 diabetes drugs - EurekAlert!

Penn researchers use AI to surface unreported GLP-1 side effects in Reddit posts - EurekAlert!

AI-based monitoring reveals protein deficiencies in people taking GLP-1 receptor agonists for weight loss - EurekAlert!

How well GLP-1 weight loss drugs work may depend on your genetics

GLP-1 receptor agonists and noncardiometabolic outcomes - EurekAlert!

As demand for GLP-1 pills and shots surges, healthy habits are still key

GLP-1 microdosers are chasing longevity

Beyond weight loss—how the GLP-1 story is evolving

Wegovy may have highest eye stroke and sight loss risk of semaglutide GLP-1 agonists— Odds of ischaemic optic neuropathy(caused by inadequate/interrupted blood flow to the optic nerve, resulting in sudden vision loss in one or both eyes) nearly 5 times higher than among users of Ozempic